[Outpatient treatment of patients with cardiovascular diseases]

G Brenner1, L Altenhofen, H Kerek-Bodden

  • 1Zentralinstitut für die kassenärztliche Versorgung, Köln. GBrenner@KBV.de

Herz
|September 19, 2000
PubMed

Insights

Cardiovascular disease management in Germany, focusing on hypertension and lipometabolism disorders, improves patient quality of life and prevents premature death through integrated outpatient and inpatient care.

Area of Science:

  • Cardiology
  • Public Health
  • General Practice

Background:

  • Cardiovascular diseases are a leading cause of treatment in German general practices and specialist offices.
  • Approximately 18 million patients in Germany suffer from circulatory diseases, with a significant portion over 70 years old receiving treatment for hypertension.
  • Effective monitoring and therapeutic interventions are crucial for managing cardiovascular conditions and preventing secondary diseases.

Purpose of the Study:

  • To highlight the importance of hypertension and lipometabolism disorder management in outpatient settings.
  • To demonstrate the impact of integrated care on patient outcomes and quality of life.
  • To analyze trends in cardiovascular disease treatment and prevention strategies.

Main Methods:

  • Analysis of treatment data from general practitioners and internal specialists in Germany.
  • Monitoring of cardiovascular disease prevalence and mortality rates.
  • Evaluation of the effectiveness of outpatient and inpatient interventions, including bypass surgery.

Main Results:

  • The average mortality age for patients with circulatory diseases is 79.4 years.
  • Treatment success is evidenced by decreasing age-standardized rates of cardiac infarctions, particularly in men, and reduced mortality in patients under 65.
  • Increased outpatient treatment is complemented by inpatient procedures like bypass surgery.

Conclusions:

  • Integrated outpatient and inpatient care significantly enhances service provision for cardiovascular patients.
  • Concerted actions in both sectors contribute to improved quality of life and prevention of early mortality.
  • The management of hypertension and lipometabolism disorders is a key strategy in reducing cardiovascular disease burden.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...